Results 231 to 240 of about 1,583,705 (314)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Long-term outcomes of lung transplantation in the elderly: an analysis using the UNOS database. [PDF]

open access: yesJ Thorac Dis
Shtraichman O   +8 more
europepmc   +1 more source

From laparoscopy to robotics in living donor hepatectomy: a systematic review and meta-analysis of comparative outcomes. [PDF]

open access: yesJ Robot Surg
Al Sayed M   +8 more
europepmc   +1 more source

Association of PIRCHE scores and allograft injury in kidney transplant recipients. [PDF]

open access: yesFront Immunol
Molnar MZ   +6 more
europepmc   +1 more source

Association Between Sex and Kidney Transplant Referral, Living Donor Contacts, Waitlisting and Kidney Transplant: A Population-Based Cohort Study. [PDF]

open access: yesCan J Kidney Health Dis
Naylor KL   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy